Oxford Nanopore Technologies Appoints Sebastian Kronmueller as Chief Business Development Officer

Oxford Nanopore Technologies Hires Sebastian Kronmueller from Royal Philips to Lead US-Based Strategy, Business Development and Partnerships, Effective January 4

Oxford Nanopore Technologies PLC, an England-based company specialising in DNA and RNA sequencing technologies, has appointed Sebastian Kronmueller as its US-based Chief Business Development Officer. He will assume the role on January 4 and lead the company’s strategy and business development functions, including partnerships.

Kronmueller joins Oxford Nanopore Technologies from Royal Philips NV, where he served as Head of Strategy and Ventures. His experience in strategy and business development is expected to support Oxford Nanopore’s efforts to strengthen its commercial strategy and expand strategic collaborations.

In his new role, Kronmueller will oversee the company’s strategy and business development activities, with a focus on building partnerships and supporting business growth. His appointment reflects Oxford Nanopore’s continued focus on advancing its position in the DNA and RNA sequencing technology market.

Oxford Nanopore Technologies develops sequencing technologies designed to analyse DNA and RNA, serving applications across research, healthcare and other life science fields.